Target Price | $16.00 |
Price | $1.64 |
Potential |
875.61%
register free of charge
|
Number of Estimates | 1 |
1 Analyst has issued a Cyclacel Pharmaceuticals, Inc. price target 2026.
The average Cyclacel Pharmaceuticals, Inc. target price is $16.00.
This is
875.61%
register free of charge
|
|
A rating was issued by 1 analysts: 0 Analysts recommend Cyclacel Pharmaceuticals, Inc. to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Cyclacel Pharmaceuticals, Inc. stock has an average upside potential 2026 of
875.61%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 0.04 | 0.10 |
90.48% | 150.00% | |
Net Margin | -28,025.00% | -2,537.00% |
417.16% | 90.95% |
1 Analyst has issued a sales forecast Cyclacel Pharmaceuticals, Inc. 2025 . The average Cyclacel Pharmaceuticals, Inc. sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued a net profit forecast Cyclacel Pharmaceuticals, Inc. 2025 . The average Cyclacel Pharmaceuticals, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -33.50 | -1.18 |
92.17% | 96.48% | |
P/E | negative | |
EV/Sales | negative |
1 Analysts have issued a Cyclacel Pharmaceuticals, Inc. forecast for earnings per share. The average Cyclacel Pharmaceuticals, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Cyclacel Pharmaceuticals, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.